AntriaBio Inc (OTCQB:ANTB)

Data as of Jan 23
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Technology Services
Internet Software/Services

Company Description

AntriaBio, Inc. is a biopharmaceutical company, which focuses on development and sale of novel therapeutic products for the diabetes market. Its products include AB 101 and AB 201. The AB 101 is administered by subcutaneous injection and targets patients with type 1 and type 2 diabetes who require basal insulin for the control of hyperglycaemia. The AB 201 supports the development of Glucagon-like peptide-1 (GLP), which helps control glucose levels. AntriaBio was founded on July 26, 2010 and is headquartered in Menlo Park, CA.

Contact Information

AntriaBio, Inc.
890 Santa Cruz Avenue
Menlo Park California 94025
P:(650) 241-9330
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Nevan Charles ElamChairman, President & Chief Executive Officer
Sankaram MantripragadaChief Scientific Officer
Brain RobertsVice President-Clinical Development
Hoyoung HuhChairman-Business Development
Noopur LiffickVice President-Corporate Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.